Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Foreword: From guest co-editors.

VanItallie TB, Tremblay J.

Metabolism. 2017 Apr;69S:S2. doi: 10.1016/j.metabol.2017.01.016. Epub 2017 Jan 11. No abstract available.

PMID:
28162774
2.

Alzheimer's disease: Innate immunity gone awry?

VanItallie TB.

Metabolism. 2017 Apr;69S:S41-S49. doi: 10.1016/j.metabol.2017.01.014. Epub 2017 Jan 11. Review.

PMID:
28129888
3.

Nicholas Pierson Christy, MD 1923-2014.

VanItallie TB.

Trans Am Clin Climatol Assoc. 2015;126:lxxxv-lxxxvii. No abstract available.

4.

Biomarkers, ketone bodies, and the prevention of Alzheimer's disease.

VanItallie TB.

Metabolism. 2015 Mar;64(3 Suppl 1):S51-7. doi: 10.1016/j.metabol.2014.10.033. Epub 2014 Oct 30. Review.

PMID:
25468143
5.

A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer's disease.

Newport MT, VanItallie TB, Kashiwaya Y, King MT, Veech RL.

Alzheimers Dement. 2015 Jan;11(1):99-103. doi: 10.1016/j.jalz.2014.01.006. Epub 2014 Oct 7.

6.

Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester.

Hashim SA, VanItallie TB.

J Lipid Res. 2014 Sep;55(9):1818-26. doi: 10.1194/jlr.R046599. Epub 2014 Mar 5. Review.

7.

Preclinical sporadic Alzheimer's disease: target for personalized diagnosis and preventive intervention.

Vanitallie TB.

Metabolism. 2013 Jan;62 Suppl 1:S30-3. doi: 10.1016/j.metabol.2012.08.024. Epub 2012 Sep 26. Review.

PMID:
23021038
8.

Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects.

Clarke K, Tchabanenko K, Pawlosky R, Carter E, Todd King M, Musa-Veloso K, Ho M, Roberts A, Robertson J, Vanitallie TB, Veech RL.

Regul Toxicol Pharmacol. 2012 Aug;63(3):401-8. doi: 10.1016/j.yrtph.2012.04.008. Epub 2012 May 3.

9.

The mitochondrial permeability transition pore provides a key to the diagnosis and treatment of traumatic brain injury.

Veech RL, Valeri CR, VanItallie TB.

IUBMB Life. 2012 Feb;64(2):203-7. doi: 10.1002/iub.590.

10.

Opioids for cancer pain: the challenge of optimizing treatment.

Plante GE, VanItallie TB.

Metabolism. 2010 Oct;59 Suppl 1:S47-52. doi: 10.1016/j.metabol.2010.07.010. Review.

PMID:
20837194
11.

Gout: epitome of painful arthritis.

VanItallie TB.

Metabolism. 2010 Oct;59 Suppl 1:S32-6. doi: 10.1016/j.metabol.2010.07.009. Review.

PMID:
20837191
12.

New therapeutics for pain--an overview.

Kalia M, Vanitallie TB.

Metabolism. 2010 Oct;59 Suppl 1:S2-4. doi: 10.1016/j.metabol.2010.07.019. No abstract available.

PMID:
20837188
13.

Fat-free mass index: changes and race/ethnic differences in adulthood.

Hull HR, Thornton J, Wang J, Pierson RN Jr, Kaleem Z, Pi-Sunyer X, Heymsfield S, Albu J, Fernandez JR, Vanitallie TB, Gallagher D.

Int J Obes (Lond). 2011 Jan;35(1):121-7. doi: 10.1038/ijo.2010.111. Epub 2010 Jun 8.

14.

Parkinson disease: primacy of age as a risk factor for mitochondrial dysfunction.

Vanitallie TB.

Metabolism. 2008 Oct;57 Suppl 2:S50-5. doi: 10.1016/j.metabol.2008.07.015. Review.

PMID:
18803967
15.

Sleep and energy balance: Interactive homeostatic systems.

Vanitallie TB.

Metabolism. 2006 Oct;55(10 Suppl 2):S30-5. Review.

PMID:
16979424
16.

Subsyndromal depression in the elderly: underdiagnosed and undertreated.

VanItallie TB.

Metabolism. 2005 May;54(5 Suppl 1):39-44. Review.

PMID:
15877312
17.

Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study.

Vanitallie TB, Nonas C, Di Rocco A, Boyar K, Hyams K, Heymsfield SB.

Neurology. 2005 Feb 22;64(4):728-30.

PMID:
15728303
18.

Ancel Keys: a tribute.

Vanitallie TB.

Nutr Metab (Lond). 2005 Feb 14;2(1):4.

19.

The escalating pandemics of obesity and sedentary lifestyle. A call to action for clinicians.

Manson JE, Skerrett PJ, Greenland P, VanItallie TB.

Arch Intern Med. 2004 Feb 9;164(3):249-58. Review.

PMID:
14769621
20.

Ketones: metabolism's ugly duckling.

VanItallie TB, Nufert TH.

Nutr Rev. 2003 Oct;61(10):327-41. Review.

PMID:
14604265
21.

Frailty in the elderly: contributions of sarcopenia and visceral protein depletion.

Vanitallie TB.

Metabolism. 2003 Oct;52(10 Suppl 2):22-6. Review.

PMID:
14577059
22.

Stress: a risk factor for serious illness.

Vanitallie TB.

Metabolism. 2002 Jun;51(6 Suppl 1):40-5. Review.

PMID:
12040540
23.

Treatment of obesity: can it become a science?

VanItallie TB.

Obes Res. 1999 Nov;7(6):605-6. No abstract available.

24.

Annual deaths attributable to obesity in the United States.

Allison DB, Fontaine KR, Manson JE, Stevens J, VanItallie TB.

JAMA. 1999 Oct 27;282(16):1530-8.

PMID:
10546692
25.

Weight loss increases and fat loss decreases all-cause mortality rate: results from two independent cohort studies.

Allison DB, Zannolli R, Faith MS, Heo M, Pietrobelli A, VanItallie TB, Pi-Sunyer FX, Heymsfield SB.

Int J Obes Relat Metab Disord. 1999 Jun;23(6):603-11.

PMID:
10411233
26.

Prevalence of obesity.

VanItallie TB.

Endocrinol Metab Clin North Am. 1996 Dec;25(4):887-905. Review.

PMID:
8977051
27.

The role of dexfenfluramine in the regulation of energy balance. Introduction.

VanItallie TB.

Metabolism. 1995 Feb;44(2 Suppl 2):1-3. No abstract available.

PMID:
7869928
28.

Introduction: the indirect socioeconomic costs of obesity.

Björntorp P, VanItallie TB.

Pharmacoeconomics. 1994;5(Suppl 1):53. No abstract available.

PMID:
10147250
29.

Introduction: the medical cost of obesity.

Björntorp P, VanItallie TB.

Pharmacoeconomics. 1994;5(Suppl 1):33. No abstract available.

PMID:
10147246
30.

Worldwide epidemiology of obesity.

VanItallie TB.

Pharmacoeconomics. 1994;5(Suppl 1):1-7. Review.

PMID:
10147243
31.

Clinical correlates of short- and long-term weight loss.

Wadden TA, Foster GD, Wang J, Pierson RN, Yang MU, Moreland K, Stunkard AJ, VanItallie TB.

Am J Clin Nutr. 1992 Jul;56(1 Suppl):271S-274S. doi: 10.1093/ajcn/56.1.271S.

PMID:
1615899
32.

Height-normalized indices of the body's fat-free mass and fat mass: potentially useful indicators of nutritional status.

VanItallie TB, Yang MU, Heymsfield SB, Funk RC, Boileau RA.

Am J Clin Nutr. 1990 Dec;52(6):953-9.

PMID:
2239792
33.

Using nature to understand nurture.

VanItallie TB, Stunkard AJ.

Am J Public Health. 1990 Jun;80(6):657-8. No abstract available.

34.

The perils of obesity in middle-aged women.

VanItallie TB.

N Engl J Med. 1990 Mar 29;322(13):928-9. No abstract available.

PMID:
2314426
35.

Rats enriched with odd-carbon fatty acids: maintenance of liver glycogen during starvation.

VanItallie TB, Khachadurian AK.

Science. 1969 Aug 22;165(3895):811-3.

PMID:
5796557
36.

TREATMENT OF MALABSORPTION SYNDROME AND EXUDATIVE ENTEROPATHY WITH SYNTHETIC MEDIUM CHAIN TRIGLYCERIDES.

HOLT PR, HASHIM SA, VANITALLIE TB.

Am J Gastroenterol. 1965 Jun;43:549-59. No abstract available.

PMID:
14296654
37.

CHOLESTYRAMINE RESIN THERAPY FOR HYPERCHOLESTEREMIA: CLINICAL AND METABOLIC STUDIES.

HASHIM SA, VANITALLIE TB.

JAMA. 1965 Apr 26;192:289-93. No abstract available.

PMID:
14271976
38.

EFFECT OF A SERUM CHOLESTEROL-LOWERING DIET ON COMPOSITION OF DEPOT FAT IN MAN.

Christakis GJ, Rinzler SH, Archer M, Hashim SA, Vanitallie TB.

Am J Clin Nutr. 1965 Feb;16:243-51. doi: 10.1093/ajcn/16.2.243. No abstract available.

PMID:
14253897
39.

CLINICAL AND PHYSIOLOGIC ASPECTS OF OBESITY.

HASHIM SA, VANITALLIE TB.

J Am Diet Assoc. 1965 Jan;46:15-9. No abstract available.

PMID:
14256209
40.

EFFECT OF TWEEN 80 ON CHOLESTYRAMINE-INDUCED MALABSORPTION.

DUBOIS JJ, HOLT PR, KURON GW, HASHIM SA, VANITALLIE TB.

Proc Soc Exp Biol Med. 1964 Oct;117:226-9. No abstract available.

PMID:
14223277
41.

TREATMENT OF CHYLURIA AND CHYLOTHORAX WITH MEDIUM-CHAIN TRIGLYCERIDE.

HASHIM SA, ROHOLT HB, BABAYAN VK, VANITALLIE TB.

N Engl J Med. 1964 Apr 9;270:756-61. No abstract available.

PMID:
14107314
42.

DRUGS REDUCING LIPIDS.

VANITALLIE TB.

Listing Res Cardiovasc Field. 1964;10:390-2. No abstract available.

PMID:
24547500
43.

AN AUTOMATICALLY MONITORED FOOD DISPENSING APPARATUS FOR THE STUDY OF FOOD INTAKE IN MAN.

HASHIM SA, VANITALLIE TB.

Fed Proc. 1964 Jan-Feb;23:82-4. No abstract available.

PMID:
14114700

Supplemental Content

Loading ...
Support Center